Skip to main content

Advertisement

Log in

Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To analyze the clinical practice guideline (CPG) development on 11 common diseases with Chinese medicine (CM) interventions in China.

Methods

The CPGs of 11 common diseases which could be treated effectively with CM had been published between 1980 and 2010 in China. The 11 diseases include coronary heart disease (angina pectoris), hypertension, chronic gastritis, rheumatoid arthritis, cerebral infarction, migraine, diabetes, primary osteoporosis, insomnia, common cold, and IgA nephropathy. The issuing organization, date of publication, development methods, and citation rate of the CPGs were analyzed. According to the development method, each guideline was categorized as consensus-based (CB), evidence-based (EB), or consensus based with no explicit consideration of evidence-based (CB-EB).

Results

Thirty-three CPGs on the 11 common diseases were found: 20 guidelines were classified as CB, 13 as CB-EB and none as EB. Fifteen CPGs were issued by the China Association of Chinese Medicine, 8 by professional working groups, and 4 by the State Administration of Traditional Chinese Medicine. Six guidelines were published between 1980 and 1990, 9 between 1991 and 2000, and 18 between 2001 and 2010. Fifty-eight percent of these guidelines have not been amended timely. Only 54.5% (18/33) of the 33 guidelines were cited by other researchers and 45.5% (15/33) percent had never been cited.

Conclusions

Most CPGs developed for 11 common diseases with CM approaches in China are consensus, and their citation rates are relatively low. The results suggest that more EB CPG or CPG strictly based on expert consensus could be developed, and great efforts should be made for future CM CPG application.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline developers handbook. http://www.sign.ac.uk/guidelines/fulltext/50.

  2. Cruse H, Winiarek M, Marshburn J, Clark O, Djulbegovic B. Quality and methods of developing practice guidelines. BMC Health Serv Res 2002;2:1–7.

    Article  PubMed  Google Scholar 

  3. New Zealand Guidelines Group. Handbook for the preparation of explicit evidence-based clinical practice guidelines. New Zealand Guidelines Group 2001:1–157.

  4. Association of Community Cancer Centers. Oncology patient management guidelines. Breast Carcinoma Version 3.0 ACCC 1999.

  5. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 8. Adjuvant systemic therapy for women with node-positive breast cancer. Can Med Assoc J 1998;158(3 Suppl):S52–S64.

    Google Scholar 

  6. Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network. Oncology (Williston park) 1999;13(5A):41–66.

  7. National Research Symposium on Coronary Heart Disease Pattern Differentiation. Coronary heart disease syndrome differention standard for Chinese medicine. J Tradit Chin Med (Chin) 1980;21(8):46.

    Google Scholar 

  8. Stroke Council of Society of Internal Medicine, China Association of Chinese Medicine. Standard for diagnosis and efficacy evaluation of stroke with Chinese medicine. China J Tradit Chin Med Pharm (Chin) 1986;1(2):56.

    Google Scholar 

  9. Working Group of TCM Diagnostic Criterion for Disease Name. Standard for diagnosis of disease name with Chinese medicine. Changsha: Hunan Academy of Chinese medicine; 1987:1–661.

    Google Scholar 

  10. Society of Internal Medicine of China Association of Traditional Chinese Medicine. Standard for the diagnosis and efficacy evaluation of cardiac obstruction. China J Tradit Chin Med Pharm (Chin) 1988;3(2):66.

    Google Scholar 

  11. China Professional Committee of Chinese and Western Medicine with Digestive System. Standard for diagnosis, syndrome differention and efficacy of chronic gastritis with integrated traditional and Western medicine. Chin J Integr Tradit West Med (Chin) 1990;10:318–319.

    Google Scholar 

  12. Traditional Chinese Medicine & emergency Collaborative Group. Standard for diagnosis and treatment of emergency syndrome of thoracic obstruction heartache. State Administration Tradit Chin Med (Chin) 1990:64–74.

  13. State Administration of Traditional Chinese Medicine. Standard for diagnosis and efficacy of Chinese medicine syndrome. Nanjing: Nanjing University Publishing House; 1994:1–326.

    Google Scholar 

  14. Collaborative Group of Cerebral Emergency Research of State Administration of Traditional Chinese Medicine. Standard for pattern differentiation of stroke (Trial). J Beijing Univ Tradit Chin Med (Chin) 1994;17(3):64–65.

    Google Scholar 

  15. Traditional Chinese Medicine & emergency Collaborative Group. Standard for diagnosis and treatment of Chinese medicine internal emergency. State Administration Tradit Chin Med (Chin) 1994:1–107.

  16. Professional Committee of Rheumatism, China Association of Chinese Medicine. Standard for diagnosis and pattern differentiation of Wangbi. Conference Proceeding (Chin) 1996.

  17. Collaborative Group of Cerebral Emergency of State Administration of Traditional Chinese Medicine. Standard for diagnosis and efficacy evaluation of stroke (Trial). J Beijing Univ Tradit Chin Med (Chin) 1996;19(1):55–56.

    Google Scholar 

  18. State Bureau of Technical Supervision. Clinical diagnosis and treatment terminology of Chinese medicine. Beijing: China Standard Press; 1997:1–103.

    Google Scholar 

  19. Collaborative Group of Emergency of State Administration of Traditional Chinese Medicine. Head wind disease syndrome diagnostic criteria. J Beijing Univ Tradit Chin Med (Chin) 1997;20(4):48–49.

    Google Scholar 

  20. IgA Nephropathy Collaboration Center of China Professional Committee for Nephropathy with Traditional Chinese Medicine. Standard for efficacy evaluation of IgA nephropathy. Conference Proceeding (Chin) 1998.

  21. Osteoporosis Working Group of Osteoporosis Committee of China Association of Gerontology. Suggestion on diagnostic criteria of osteoporosis for Chinese (2nd ed). Chin J Osteoporos (Chin) 2000;6:1–3.

    Google Scholar 

  22. Shen SG, Wang CD, Yan XJ. Standard for diagnosis, efficacy and treatment of heart disease with Chinese medicine. Beijing: Beijing Publishing House of Science and Technology; 2002:1–179.

    Google Scholar 

  23. State Food and Drug Administration. Guiding principle of clinical researches on new drugs of traditional Chinese medicine. Beijing: China Medical Science and Technology Press; 2002:53–392.

    Google Scholar 

  24. Diabetes professional committee of China Association of Integrated Chinese and Western Medicine. Standard for diagnosis and therapeutic efficacy evaluation of diabetes mellius in integrative Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2005;25:94–95.

    Google Scholar 

  25. Expert Consensus Group of Definitions, Diagnosis and Treatment with Drugs of Insomnia. Guideline for definitions, diagnosis and treatment with drugs of insomnia (draft). Chin J Neurol (Chin) 2006;2:141–143.

    Google Scholar 

  26. Guideline Developing Group. A guideline for pre-clinical and clinical assessment on prevention and treatment of osteoporosis with traditional Chinese drugs. Beijing: People’s Medical Publishing House; 2006:1–77.

    Google Scholar 

  27. China Association of Chinese Medicine. Guidelines for Chinese medicine diabetes prevention and treatment. Beijing: China Press of Traditional Chinese Medicine; 2007:1–87.

    Google Scholar 

  28. Nephropathy Committee of China Association of Chinese Medicine. Standard for diagnosis, syndrome type and efficacy assessment of IgA nephropathy. Shanghai J Trad Chin Med (Chin) 2007;41(5):9–10.

    Google Scholar 

  29. China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine disease of modern medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:1–305.

    Google Scholar 

  30. China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine symptoms in Chinese medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:1–147.

    Google Scholar 

  31. Song J, Chen KJ. Set clinical therapeutic guideline in traditional medicine urgently. Chin J Integr Tradit West Med (Chin) 2006;26:581–584.

    Google Scholar 

  32. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992;268:240–248.

    Article  PubMed  CAS  Google Scholar 

  33. Mulrow CD. Systematic reviews: rationale for systematic reviews. BMJ 1994;309:597–599.

    Article  PubMed  CAS  Google Scholar 

  34. Field M, Lohr K. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: direction for a new program. Washington DC: National Academy Press; 1990:1–160.

    Google Scholar 

  35. Canadian Medical Association. Guidelines for Canadian clinical practice guidelines [2007-5-8]. http://mdm.ca/cpgsnew/cpgs/gccpg-e.htm.

  36. Jin ZC. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. J Chin Integr Med (Chin) 2008;6:5–8.

    Article  Google Scholar 

  37. Institute of Medicine. Guideline for clinical practice: from development to use. Washington DC: National Academic Press; 1992:1–241.

    Google Scholar 

  38. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. http://www.agreecollaboration.iorg/instrument.

  39. Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D. A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Intern J Quality Health Care 2005;17:235–242.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ai-ping Lu  (吕爱平).

Additional information

Supported by National Natural Science Foundation of China (No. 30825047), the Projects from State Administration of Traditional Chinese Medicine (No. ZYYS-2008), and China Academy of Chinese Medical Sciences (No. Z0135 and Z02128 and Z02114)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuwen, Y., Shi, Nn., Wang, Ly. et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China. Chin. J. Integr. Med. 18, 112–119 (2012). https://doi.org/10.1007/s11655-012-0997-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-0997-y

Keywords

Navigation